UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
RPC Inc
RES
$1.3B
| $451K | ﹤0.01% |
65,299
+23,486
| +56% | +$224K |
|
2352
Kinetik
KNTK
$7.98B
| $451K | ﹤0.01% |
+13,200
| New | +$489K |
|
|
NGM
2353
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $444K | ﹤0.01% |
34,663
+16,034
| +86% | +$222K |
|
|
AMRS
2354
DELISTED
Amyris Inc.
AMRS
| $441K | ﹤0.01% |
238,238
+21,214
| +10% | +$62.4K |
|
2355
Dr. Reddy's Laboratories
RDY
$10.2B
| $440K | ﹤0.01% |
39,735
| – | – |
|
|
ACCD
2356
DELISTED
Accolade Inc
ACCD
| $436K | ﹤0.01% |
58,944
-1,620
| -3% | -$14.2K |
|
2357
BlueLinx
BXC
$706M
| $436K | ﹤0.01% |
+6,524
| New | +$490K |
|
2358
Clear Channel Outdoor Holdings
CCO
$1.23B
| $434K | ﹤0.01% |
405,435
+107,991
| +36% | +$226K |
|
2359
Tejon Ranch
TRC
$451M
| $433K | ﹤0.01% |
27,868
| – | – |
|
2360
Geron
GERN
$949M
| $429K | ﹤0.01% |
276,819
| – | – |
|
|
FNA
2361
DELISTED
Paragon 28, Inc.
FNA
| $426K | ﹤0.01% |
+26,852
| New | +$452K |
|
2362
nLIGHT
LASR
$3.17B
| $421K | ﹤0.01% |
41,192
+7,708
| +23% | +$99.5K |
|
2363
Stagwell
STGW
$2.24B
| $421K | ﹤0.01% |
77,513
+19,513
| +34% | +$138K |
|
2364
Recursion Pharmaceuticals
RXRX
$1.73B
| $419K | ﹤0.01% |
51,453
+3,259
| +7% | +$21.8K |
|
2365
Anterix
ATEX
$1.94B
| $418K | ﹤0.01% |
10,189
+2,074
| +26% | +$101K |
|
2366
OneSpan
OSPN
$618M
| $417K | ﹤0.01% |
35,029
+1,155
| +3% | +$15.2K |
|
2367
Clearfield
CLFD
$374M
| $416K | ﹤0.01% |
6,713
-3,200
| -32% | -$188K |
|
2368
Pennant Group
PNTG
$1.36B
| $415K | ﹤0.01% |
32,435
+4,768
| +17% | +$79.3K |
|
2369
EverQuote
EVER
$906M
| $413K | ﹤0.01% |
46,684
+28,160
| +152% | +$322K |
|
|
ORGN
2370
DELISTED
Origin Materials
ORGN
| $411K | ﹤0.01% |
2,673
| – | – |
|
2371
Kodiak Sciences
KOD
$2.84B
| $410K | ﹤0.01% |
53,663
+15,041
| +39% | +$106K |
|
2372
Energy Vault
NRGV
$633M
| $410K | ﹤0.01% |
+40,874
| New | +$531K |
|
|
NP
2373
DELISTED
Neenah, Inc. Common Stock
NP
| $409K | ﹤0.01% |
11,974
-5,206
| -30% | -$195K |
|
|
MRSN
2374
DELISTED
Mersana Therapeutics
MRSN
| $408K | ﹤0.01% |
3,535
| – | – |
|
|
WW
2375
DELISTED
WW International
WW
| $408K | ﹤0.01% |
63,858
+10,656
| +20% | +$89.6K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.